Frappe P, Buchmuller-Cordier A, Bertoletti L, Bonithon-Kopp C, Couzan S, Lafond P, et al; STEPH Study Group. Annual Diagnosis Rate of Superficial Vein Thrombosis of the Lower Limbs: The STEPH Community-Based Study. J Thromb Haemost 2014;12:831-8.
DOI: 10.1111/jth.12575
Di Minno G, Mannucci PM, Tufano A, Palareti G, Moia M, Baccaglini U, et al. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J Thromb Haemost 2005;3:1459-66.
DOI: 10.1111/j.1538-7836.2005.01458.x
Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O’’Fallon WM, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-63.
DOI: 10.1055/s-0037-1616243
6Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg 2003;37:834-8.
DOI: 10.1067/mva.2003.157
Barrellier MT. Superficial venous thromboses of the legs. Phlebologie 1993;46:633-9.
De Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost 1998;80:239-41.
DOI: 10.1055/s-0037-1615180
Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg 1998;27:338-43.
DOI: 10.1016/S0741-5214(98)70364-7
León L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis.Eur J Vasc Endovasc Surg 2005;29:10-7.
DOI: 10.1016/j.ejvs.2004.09.021
Decousus H, Epinat M, Guillot K, Quenet S, Boissier C, Tardy B. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med 2003;9:393-7.
DOI: 10.1097/00063198-200309000-00009
1Binder B, Lackner HK, Salmhofer W, Kroemer S, Custovic J, Hof-mann-Wellenhof R. Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities. Arch Dermatol 2009;145:753-7.
DOI: 10.1001/archdermatol.2009.123
Verlato F, Zucchetta P, Prandoni P, Camporese G, Marzola MC, Salmistraro G, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999;30:1113-5.
DOI: 10.1016/S0741-5214(99)70051-0
Kim SH, Patel N, Thapar K, Pandurangadu AV, Bahl A. Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism. Vasc Health Risk Manag 2018;14:129-35.
DOI: 10.2147/VHRM.S164190
Barco B, Pomero F, Di Minno G, Tamborini Permunian E, Malato A, et al. Clinical Course of Patients With Symptomatic Isolated Superficial Vein Thrombosis: The ICARO Follow-Up Study. J Thromb Haemost 2017;15:2176-83.
DOI: 10.1111/jth.13840
1Galanaud JP, Blaise S, Sevestre MA, Terrisse H, Pernod G, Gaillard C, et al; OPTIMEV-SFMV investigators. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Thromb Res 2018;171:179-86.
DOI: 10.1016/j.thromres.2018.04.013
Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M, et al; POST (Prospective Observational Superficial Thrombophlebitis) Study Group. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152:218-24.
DOI: 10.7326/0003-4819-152-4-201002160-00006
Gorty S, Patton-Adkins J, DaLanno M, Starr J, Dean S, Satiani B. Superficial venous thrombosis of the lower extremities: analysis of risk factors, and recurrence and role of anticoagulation. Vasc Med 2004;9:1-6.
DOI: 10.1191/1358863x04vm516oa
Ascher E, Hanson JN, Salles-Cunha S, Hingorani A. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. Vasc Endovasc Surg 2003;37:421-7.
DOI: 10.1177/153857440303700606
Gillet JL, Perrin M, Cayman R. Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients. J Mal Vasc 2001;26:16-22.
Gillet JL, Allaert FA, Perrin M. Superficial thrombophlebitis in non varicose veins of the lower limbs. A prospective analysis in 42 patients. J Mal Vasc 2004;29:263-72.
DOI: 10.1016/S0398-0499(04)96771-6
Milio G, Siragusa S, Minà C, Amato C, Corrado E, Grimaudo S, et al. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins. Thromb Res 2008;123:194-9.
DOI: 10.1016/j.thromres.2008.01.013
Milio G, Siragusa S, Malato A, Grimaudo S, Pinto A. Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins. Int Angiol 2009;28:298-302.
Mouton WG, Kienle Y, Muggli B, Naef M, Wagner HE. Tumors associated with superficial thrombophlebitis. Vasa 2009;38:167-70.
DOI: 10.1024/0301-1526.38.2.167
Lozano Sánchez FS, González-Porras JR, Zarco Castillo J, Alberca Silva I. La trombosis venosa superficial: ¿es una enfermedad benigna?. Angiologia 2011;63:25-30.
DOI: 10.1016/S0003-3170(11)70065-7
Solimeno G, Valitutti P. A haemodynamic concept in the management of superficial non-saphenous vein thrombosis. Phlebology 2019 Jul 27:268355519861462.
DOI: 10.1177/0268355519861462
Cesarone MR, Belcaro G, Agus G, Georgiev M, Errichi BM, Marinucci R, et al. Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. Angiology 2007;58 Suppl 1:7S-14S.
DOI: 10.1177/0003319706297643
Titon JP, Auger D, Grange P, Hecquet JP, Remond A, Ulliac P, et al. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent. Ann Cardiol Angeiol (Paris) 1994;43:160-6.
Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, De Sanctis MT, Incandela L, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999;50:523-9.
DOI: 10.1177/000331979905000701
Marchiori A, Verlato F, Sabbion P, Camporese G, Rosso F, Mosena L, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study Haematologica 2002;87:523-7.
Lozano FS, Almazán A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovasc Surg 2003;37:415-20.
DOI: 10.1177/153857440303700605
Katzenschlager R, Ugurluoglu A, Minar E, Hirschl M. Liposomal Heparin-Spraygel in Comparison with Subcutaneous Low Molecular Weight Heparin in Patients with Superficial Venous Thrombosis. A Randomized, Controlled, Open Multicentre Study J Kardiol 2003;10:375-8.
Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003;163:1657-63.
DOI: 10.1001/archinte.163.14.1657
Prandoni P, Tormene D, Pesavento R; Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the
Gorski G, Szopiński P, Michalak J, Marianowska A, Borkowski M, Geremek M, et al. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005;56:9-17.
DOI: 10.1177/000331970505600102
Uncu H. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis. Phlebology 2009;24:56-60.
DOI: 10.1258/phleb.2008.008025
Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al; CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
N Engl J Med 2010;363:1222-32.
Cosmi B, Filippini M, Tonti D, Avruscio G, Ghirarduzzi A, Bucherini E, et al; STEFLUX Investigators. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). J Thromb Haemost 2012;10:1026-35.
DOI: 10.1111/j.1538-7836.2012.04727.x
Rathbun SW, Aston CE, Whitsett TL. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. J Thromb Haemost 2012;10:833-9.
DOI: 10.1111/j.1538-7836.2012.04669.x
Spirkoska A, Jezovnik MK, Poredos P. Time course and the recanalization rate of superficial vein thrombosis treated with low-molecular-weight heparin. Angiology 2015;66:381-6.
DOI: 10.1177/0003319714533183
Beyer-Westendorf J. Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis. Hematology 2017;2017:223-30.
DOI: 10.1182/asheducation-2017.1.223
Giannoukas A, Karathanos C, Nikolakopoulos K, Georgiadis GS, Maltezos C, Ioannou C, et al; SeVEN Collaborators. Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: Results from an observational multicenter study-SeVEN study. Phlebology 2018;33:636-45.
DOI: 10.1177/0268355517748540
Wichers IM, Di Nisio M, Buller HR, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 2005;90:672-7.
Marchiori A, Mosena L, Prandoni P. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Semin Thromb Hemost 2006;32:737-43.
DOI: 10.1055/s-2006-951459
Di Nisio M, Wichers I, Middeldorp S. Treatment of Lower Extremity Superficial Thrombophlebitis. JAMA 2018;320:2367-8.
DOI: 10.1001/jama.2018.16623
Scovell SD, Ergul EA, Conrad MF. Medical management of acute superficial vein thrombosis of the saphenous vein. J Vasc Surg Venous Lymphat Disord 2018;6:109-17.
DOI: 10.1016/j.jvsv.2017.08.016
Duffett L, Kearon C, Rodger M, Carrier M. Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis. Thromb Haemost 2019;119:479-89.
DOI: 10.1055/s-0039-1677793
Blondon M, Righini M , Bounameaux H , Veenstra DL. Fondaparinux for Isolated Superficial Vein Thrombosis of the Legs: A Cost-Effectiveness Analysis. Chest 2012;141:321-9.
DOI: 10.1378/chest.11-0625
Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):401S-28S.
DOI: 10.1378/chest.126.3_suppl.401S
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6Suppl):454S-545S.
DOI: 10.1378/chest.08-0658
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e419S-e96S.
DOI: 10.1378/chest.141.5.1369b
Frías M, García O, Vázquez N, Rial R, Carrasco E, Moñux G, et al. Documento de consenso de la Sociedad Española de Médicos de Atención Primaria y Capítulo Español de Flebología y Linfología de la Sociedad Española de Angiología y Cirugía Vascular: trombosis venosa superficial de miembros inferiores en Atención Primaria. Medicina de Familia (SEMERGEN) 2019;45:187-96.
DOI: 10.1016/j.semerg.2018.08.006
Número de descargas:
51047
Número de visitas:
2944
Citas:
0
